Evidence mapPaperPMID 30709341Full record

ArticleBMC nephrology2019

Clinical outcomes of hemodialysis patients in a public-private partnership care framework in Italy: a retrospective cohort study.

L A Pedrini, A C Winter, F Cerino, A M Zawada, M Garbelli, A Feuersenger, A Feliciani, P Ruggiero, S Civardi, C Amato and 4 more

Abstract read
In one paragraph

Article in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

L A PedriniDepartment of Nephrology and DialysisNephroCare-ASST Bergamo-Est, Seriate, Italy.
A C WinterFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
F CerinoNephroCare S.p.A., Naples, Italy.
A M ZawadaFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany. Adam.Zawada@fmc-ag.com.
M GarbelliFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
A FeuersengerFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
A FelicianiDepartment of Nephrology and DialysisNephroCare-ASST Bergamo-Est, Seriate, Italy.
P RuggieroDepartment of Nephrology and DialysisNephroCare-ASST Bergamo-Est, Seriate, Italy.
S CivardiFresenius Medical Care Italia S.p.A, Palazzo Pignano, Italy.
C AmatoFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
B CanaudFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
S StuardFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
A KarchFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.
A GaulyFresenius Medical Care Deutschland GmbH, Bad Homburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInnovative care models such as public-private partnerships (PPPs) may help meet the challenge of providing cost-effective high-quality care for the steadily growing and complex chronic kidney disease population since they combine the expertise and efficiency of a specialized dialysis provider with the population care approach of a public entity. We report the five-years main clinical outcomes of a population of patients treated on hemodialysis within a PPP-care model in Italy.

methodsThis descriptive retrospective cohort study consisted of all consecutive hemodialysis patients treated in the NephroCare-operated Nephrology and Dialysis unit of the Seriate Hospital in 2012-2016, which exercises a PPP-care model. Clinical and treatment information was obtained from the European Clinical Database. Hospitalization outcomes and cumulative all-cause mortality incidences that accounted for competing risks were calculated.

resultsWe included 401 hemodialysis patients (197 prevalent and 204 incident patients) in our study. The mean cohort age and age-adjusted Charlson Comorbidity Index were 67.0 years and 6.7, respectively. Patients were treated with online high-volume hemodiafiltration or high-flux hemodialysis. Parameters of treatment efficiency were above the recommended targets throughout the study period. Patients in the PPP experienced benefits in terms of hospitalization (average number of hospital admissions/patient-year: 0.79 and 1.13 for prevalent and incident patients, respectively; average length of hospitalization: 8.9 days for both groups) and had low cumulative all-cause mortality rates (12 months: 10.6 and 7.8%, 5 years: 42.0 and 35.9%, for prevalent and incident patients, respectively).

conclusionsResults of our descriptive study suggest that hemodialysis patients treated within a PPP-care model framework received care complying with recommended treatment targets and may benefit in terms of hospitalization and mortality outcomes.

Indexed as

Public-Private Sector PartnershipsAgedAged, 80 and overComorbidityFemaleFollow-Up StudiesHemodiafiltrationHemodialysis Units, HospitalHospitalizationHumansIncidenceItalyKidney Failure, ChronicMaleMiddle AgedMortalityHemodialysis, Hemodiafiltration, Survival, Outcome, Hospitalization, Outsourcing, Public private partnership

Identifiers

PMID30709341
PMCPMC6359808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.